Breaking Down Barriers to ‘Living Medicines:’ California’s New Plan to Partner with Industry to Manufacture ‘Transformative’ Treatments
One ambitious and major objective of the California stem cell agency over the next five years is to create a “public-private manufacturing partnership network” that would remove current barriers to bringing actual treatments to large numbers of patients.
The agency’s strategic plan does not have a timetable for the effort nor does it indicate…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.